ARCHIVES

CMS Considering Regulatory Standards for Drug Company Bundling of Products.

This article is from The Cancer Letter archive.

Vol. 32 No. 37 | October 20, 2006

Download PDF Visit The Full Archive

Related Articles

NIH Acting Director Kirschstein Preparing For Budget Hearings.

January 14, 2000

Growth Of The Cost of Drugs Slows to 5.4 Percent per Year; 21 Therapies Launched in 2 Years

May 9, 2014

In Congress: HHS Funding Bill Vetoed, Congress, White House Negotiating on Budget

November 12, 1999

MD Anderson Expands Reach Into Florida, Ohio

September 26, 2014

NCI Contract Awards.

February 18, 2000

Bevacizumab Improves PFS In Advanced Kidney Cancer

July 27, 2007